These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6405544)

  • 1. [Preventable side effects of chemotherapy].
    Lenzhofer R; Dudczak R; Moser K
    Wien Med Wochenschr; 1983 Feb; 133(3):73-83. PubMed ID: 6405544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Supportive measures in aggressive cytostatic therapy].
    Urban C; Slavc I; Maurer G; Kaulfersch W; Trittenwein G
    Padiatr Padol; 1985; 20(4):343-52. PubMed ID: 3936005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Supportive care in cancer: concepts, achievements and challenges].
    Bauvet F; Klastersky J; Awada A
    Bull Cancer; 2008 Mar; 95(3):381-8. PubMed ID: 18390421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of bone marrow aplasia in phase I of acute lymphatic leukemia treatment in children].
    Tiefenbach A; Konja J; Potkonjak-Sekso M
    Bilt Hematol Transfuz; 1979; 7(1 Suppl):23-6. PubMed ID: 121957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is there an indication for parenteral nutrition support in the terminally ill cancer patient?].
    Gutman M; Singer P; Gimmon Z
    Harefuah; 2008 Mar; 147(3):224-8, 278, 277. PubMed ID: 18488864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelotoxicity from chemotherapy.
    Daniel D; Crawford J
    Semin Oncol; 2006 Feb; 33(1):74-85. PubMed ID: 16473646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
    Aapro MS; Link H
    Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anemia and chemotherapy].
    Ray-Coquard I; Bachelot T; Sebban C; Biron P; Guastalla JP; Blay JY
    Bull Cancer; 2003 Apr; 90 Spec No():S133-43. PubMed ID: 12856425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The quality of life after chemotherapy in advanced non-small cell lung cancer patients].
    Słowik-Gabryelska A; Szczepanik A; Kalicka A
    Pol Merkur Lekarski; 1999 Jan; 6(31):18-22. PubMed ID: 10344148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of epoetin alfa in chemotherapy-associated anemia.
    Jilani SM; Glaspy JA
    Semin Oncol; 1998 Oct; 25(5):571-6. PubMed ID: 9783596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients.
    Marec-Berard P; Blay JY; Schell M; Buclon M; Demaret C; Ray-Coquard I
    J Clin Oncol; 2003 Nov; 21(22):4235-8. PubMed ID: 14615453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of oral topotecan in advanced non-small cell lung cancer.
    White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
    Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Logistic regression model of fotemustine toxicity combining independent phase II studies.
    Raymond E; Haon C; Boaziz C; Coste M
    Cancer; 1996 Nov; 78(9):1980-7. PubMed ID: 8909320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complications of bone marrow suppression.
    Kay HE; Jameson B
    Proc R Soc Med; 1970 Oct; 63(10):1075-7. PubMed ID: 5483521
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment options for anemia, taking risks into consideration: erythropoiesis-stimulating agents versus transfusions.
    Spano JP; Khayat D
    Oncologist; 2008; 13 Suppl 3():27-32. PubMed ID: 18458122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in malignant disease.
    Drug Ther Bull; 1970 Feb; 8(4):13-6. PubMed ID: 5417900
    [No Abstract]   [Full Text] [Related]  

  • 19. An epidemiological review of red cell transfusions in cancer chemotherapy.
    Skillings JR; Rogers-Melamed I; Nabholtz JM; Sawka C; Gwadry-Sridhar F; Moquin JP; Rubinger M; Ganguly P; Burnell M; Shustik C; Dryer D; McLaughlin M; White D
    Cancer Prev Control; 1999 Jun; 3(3):207-12. PubMed ID: 10474769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and treatment of the side effects of cancer chemotherapy].
    Iki S; Urabe A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1635-40. PubMed ID: 11057312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.